Category: BA.5
Italy: ‘Dangerous increase’ in SARS-CoV-2 concentrations in wastewater of >30%
‘The national trend of SARS-CoV-2 concentrations in wastewater showed a “dangerous increase” (>30%) in SARS-CoV-2 concentrations in the weeks 24 and 25, 2022′. More...
Italy: Lung function impaired by BA.5 infection
Subjects hospitalized for Omicron BA.5 showed an altered endothelial function three months after the acute phase with an impairment of lung function. More...
Omicron BA.2.75 – a potential successor to BA.5
There’s another Covid storm looming on the horizon as a new subvariant of Omicron BA.2 appears to be carrying mutations that make it even fitter than BA.5. More...
France: BA.5 now dominant, Covid cases up by more than 50% in one week
BA.5 at 59%, sharp increase in Covid cases in all regions and age groups, hospital admission rate rising. More...
Germany: Covid cases up by 38% in one week
The nationwide 7-day incidence increased in week 25 compared to the previous week by almost 155,000 cases (+38%). More...
WHO: BA.5 now dominant globally
As of epidemiological week 24, BA.5 represents 43% of global sequences at Gisaid, BA.2 represents 25%, BA.4 represents 12%, and BA.2.12.1 represents 11%. More...
UK: Over 3 million symptomatic cases of Covid-19
The UK ZOE Covid app is reporting that, for the second time in just over three months, more than three million people in the UK have symptomatic Covid. More...
Preprint: BA.2.12.1, BA.4, and BA.5 substantially escape neutralizing antibodies
These data show that the BA.2.12.1, BA.4, and BA.5 subvariants substantially escape neutralizing antibodies induced by both vaccination and infection. More...
Germany: BA.5 now dominant with 50% of sequences
RKI: “The proportion of the omicron subline BA.5 was 50% in week 23, it has become the dominant variant. More...
Scotland: One person in twenty infected with Covid-19
The latest report from the Office of National Statistics shows a big increase in COVID-19 cases across the four nations of the UK, and particularly in Scotland. More...